ERBP Official Documents (from the most recent to the oldest) – click on the links for download

The new European Renal Best Practice guideline on arteriovenous access: why worthwhile to read

Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults

Considerations on glycaemic control in older and/or frail individuals with diabetes and advanced kidney disease

ERBP Guideline on Management of Older Patients with Chronic Kidney Disease
- Field version and translations available

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

Important update (2019): please note that this document was published in January 2016 and considered the Tempo 3:4 Trial and former EMA licence regarding Tolvaptan. Since then, the Tempo 4:4 results have been published, there has been a new trial (REPRISE) and an update of the EMA licence, which means that this ERBP document is outdated. ERBP cannot confirm at this time whether an update will follow.

Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min)
- Field version and translations available

Should patients with CKD Stage 5D and biochemical evidence of secondary hyperparathyroidism be prescibed calcimimetic therapy? An ERA-EDTA position statement

Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?

ERBP Guideline on the Management and evaluation of the kidney donor and recipient
- Field version and translations available

Bridging the gap between what is known and what we do in renal medicine: improving implementability of the European Renal Best Practice guidelines

Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties

A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: part 2: renal replacement therapy

Measuring the quality of renal care: things to keep in mind when selecting and using quality indicators

A systematic review regarding the association of illness perception and survival among end-stage renal disease patients

European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelines

A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Blood Pressure in Non-dialysis-dependent Chronic Kidney Disease: an endorsement with some caveats for real-life application (chinese translation available)

Providing guidance in the dark: rare renal diseases and the challenge to improve the quality of evidence

Health economics and European Renal Best Practice —is it time to bring health economics into evidence-based guideline production in Europe?

What guidelines should or should not be: implications for guideline production

ERBP GUIDELINE ON THE MANAGEMENT AND EVALUATION OF THE KIDNEY DONOR AND RECIPIENT

Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice

A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy

Crush recommendations: a step forward in disaster nephrology

Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement

When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study

Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement

Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to Reduce Cardiovascular Events with Aranesp® Therapy (TREAT) Study

Diagnosis, prevention and treatment of haemodialysis catheter-related bloodstream infections (CRBSI): a position statement of European Renal Best Practice (ERBP)

Catheter-related blood stream infections (CRBSI): a European view

Educating end-stage renal disease patients on dialysis modality selection: clinical advice from the European Renal Best Practice (ERBP) Advisory Board

Educating end-stage renal disease patients on dialysis modality selection

Evaluation of peritoneal membrane characteristics: a clinical advice for prescription management by the ERBP working group

High-flux or low-flux dialysis: A position statement following publication of the Membrane Permeability Outcome (MPO) study

The future of European Nephrology ‘Guidelines’—a declaration of intent by European Renal Best Practice (ERBP)

Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement

Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP)

European best practice quo vadis? From European best practice guidelines (EBPG) to European renal best practice (ERBP)